Abstract
Introduction
Sadoshima et al. [5] . Experiments performed in isolated neonatal rat cardiac myocytes have further demonstrated Mechanical stretch is one of the most important stimuli that ET-1 could also be detected in the cardiomyocyte leading to cardiac hypertrophy. One of the earliest events culture medium 10 min after stretch [6] . The activation of detected after stretching adult cardiac muscle is an en-MAP kinases and protein synthesis can be attenuated by 1 1 hanced activity of the Na / H exchanger (NHE) [1] . The inhibition of the NHE when promoted by stretch, but not stretch-induced activation of the NHE is the result of an after the addition of Ang II or ET-1 [7] . Furthermore, an autocrine / paracrine chain of events involving the release enhanced activity of the NHE in the hypertrophied of angiotensin II (Ang II) and endothelin (ET) [2] [3] [4] . The myocardium of the SHR [8, 9] and the normalization of release of these transmitters by stretching isolated neonatal NHE activity after enalapril-induced regression of cardiac myocytes has been recognized since the seminal paper by hypertrophy [10] have been reported. The mechanism by which mechanical stretch transmits signals to the nucleus is not completely clarified. It of the NHE in a parallel and independent fashion. If so, the for determining collagen volume fraction (CVF) or 0.32 2 enhanced activity of the NHE would be an epiphenomenon mm / pixel for determining the cross-sectional area of of the hypertrophy and chronic inhibition of the NHE cardiac muscle cells. Fifty cross-sectioned cardiac muscle should not be accompanied by a regression of myocardial fibers were counted in at least 10 images obtained from hypertrophy. In order to shed light on this crucial issue, each left ventricle. Only round to ovoid cells with visible experiments were performed in SHR in which the effect of round nucleus were considered for CSA measurements. chronic inhibition of the NHE on myocardial hypertrophy Each cell was individually traced and its cross sectional was assessed.
area directly determined. CVF was calculated as the sum of all connective tissue areas of the coronal sections, divided by the total surface of the section. Perivascular collagen was excluded from this measurement. To separate 2. Methods the stained tissues from other objects, a color segmentation was applied. The investigator responsible for the morExperiments were conducted in accordance with the phological analysis was blinded as to each experimental Guide for the Care and Use of Laboratory Animals (US group. Department of Health and Human Service) with male SHR To assess myocardial stiffness, isolated left ventricular and normotensive Wistar (NT) rats. From the age of 3 papillary muscles were mounted in a horizontal perfusion months, systolic blood pressure (SBP) was determined by chamber between a force transducer (AEM801 SensorOne) the tail-cuff method [11] . At the age of 4 months, mean and a fixed hook for isometric records. The muscles were SBP values were 12161 (NT, n541) and 17761 mmHg superfused at a constant rate (5 ml / min) with a CO / 3.0 mg / kg / day cariporide; (c) 10.0 mg / kg / day nifedipine; (pH|7.4). The preparations were stimulated by square (d) no drug (control untreated group) and (e) sacrifice to pulses of 5 ms duration, at a voltage |20% higher than the assess the degree of cardiac hypertrophy at the time of threshold. After mounting, the values of muscle slack treatment initiation. While cariporide was dissolved directlength (L ), thickness and width were determined with a 0 ly in the drinking water, nifedipine was orally administered reticle in the eyepiece of an SZ30 Olympus Zoom in a single daily dose. The concentration of cariporide in stereomicroscope set at a total magnification of 330. The the drinking water was adjusted according to weekly muscles were progressively stretched to the length at measurements of BW and daily records of water intake to which they developed the maximal twitch force (L ) in max match with the selected dosages. After 1 month, the rats steps of 10% of L . The force was normalized to the cross 0 were euthanized under ether anesthesia. Papillary muscles sectional area of each muscle, which was calculated isolated from the left ventricle were used to assess multiplying thickness by width and corrected by a factor of myocardial stiffness. After trimming off all adjacent 0.75 assuming an ellipsoidal shape. The stress-strain connective tissue and the atria, the ventricles were blotted relationship for each muscle was fitted to an exponential and weighed (HW) to determine the level of cardiac equation. From the fitted curves, fixed values of strains hypertrophy by HW normalized to BW (HW/ BW ratio, in (DL /L ) were interpolated in each experiment. max mg / g). The ventricular tissue was fixed in buffered To determine serum levels of carboxyterminal propformaldehyde 10% for 24 h. Coronal sections obtained eptide of procollagen type I (PIP), blood samples were from the equator of the left ventricle were prepared for obtained at the time of euthanasia and allowed to clot conventional histological techniques. Five-mm-thick parafspontaneously. After centrifugation, serum samples were fin-embedded sections were stained either with Mallory's separated and stored at 270 8C until assayed. Serum PIP phosphotungstic acid hematoxylin (PTAH) method or a was determined by radioimmunoassay with a commercial trichromic technique including Gill haematoxylin, xylidine assay kit (Orion Diagnostica, Finland). The lower depunceau and picric acid to differentiate fibrils and delineate tection limit (method sensitivity) was 1.2 mg/l. cell borders [12] . The trichrome Van Gieson stain technique was used for determining collagen in the muscle tissue [12] . All the stained sections were observed under the microscope (Olympus BX-50, Tokyo, Japan) and the 2.1. Statistics images were captured using an analog video camera. Images were digitized and processed by a computer Data were expressed as mean6S.E.M. One-way morphometry program (Image-Pro Plus for Windows 95 / ANOVA and two-way ANOVA were used to compare 98 v4.5-Media Cybernetics, Silver Spring, MA, USA).
differences, as appropriate. Dunnett was used as post hoc The resolution of the microscopic images was of 6403480 test. P values ,0.05 were considered to indicate signifi-
Results
SHR and their normotensive (NT) control rats were treated orally with two doses of the specific inhibitor of the NHE-1, cariporide, during 1 month. Fig. 1 shows the SBP values during this time. A slight decrease in arterial pressure following the treatment was detected in the SHR, and no effect was evident in the NT rats. The two doses of the inhibitor did not differ in their effect on blood pressure. On average, the value of systolic arterial pressure at the end of the treatment period was |6 mmHg lower in the treated SHR than in the untreated animals. We did not Fig. 2 . Effect of NHE-1 inhibition on cardiac hypertrophy in SHR. Cardiac hypertrophy was assessed by HW/ BW ratio in 4 months old explore the mechanism involved in this slight effect on untreated SHR (n510); low-dose (0.3 mg / kg / day) cariporide-treated SBP in the SHR rats. We speculate that the effect of the SHR (Low-dose SHR-cari, n515); high dose (3.0 mg / kg / day) NHE inhibitor on cell growth might decrease wall thickcariporide-treated SHR (High-dose SHR-cari, n56); nifedipine-treated ness in resistance vessels of SHR [13] .
SHR (SHR-nife, n56) and 5 months old untreated SHR (n517) rats.
The degree of cardiac hypertrophy was assessed by the Chronic treatment with cariporide for 1 month did not modify the HW/ BW ratio in NT rats at any of the dosages used. In cariporide-treated NT, HW/ BW (mg / g) ratio were 2.4760.14 (n54) and 2.5660.10 (n57) after 1-month (2.5160.08, n510) nor from age-matched untreated NT treatment with the low-and high-dosage, respectively. rats (2.5060.09, n57). These values did not differ from the HW/ BW determined Chronic NHE-1 inhibition induced a slight decrease in in untreated NT rats at the age of treatment initiation arterial pressure together with a partial regression of the myocardial hypertrophy, thus making it interesting to compare these two effects, namely the decrease in arterial pressure and the decrease in myocardial hypertrophy induced by the NHE-1 inhibitor, with those induced by a primary antihypertensive pharmacological intervention such as nifedipine blockade of calcium channels. Since the effect of dihydropyridines on hypertensive myocardium is well established [14] [15] [16] [17] [18] and this study was particularly focused on the action of NHE-1 blockade, the experiments with nifedipine were aimed only to compare the relationship between the reduction in SBP and the degree of cardiac hypertrophy regression achieved by both treatments. A similar decrease in the degree of hypertrophy was obtained with cariporide and nifedipine ( Fig. 2) but with an approximately sixfold greater decrease in SBP after nifedipine-treatment (Fig. 1) . The decrease in arterial pressure was only 5.761.7 and 5.661.6 mmHg with the low and high dose of cariporide, respectively, and 35.667.4 mmHg with nifedipine (P,0.05). untreated age-matched NT rats. Fig. 4 shows representative photomicrographs of left ventricular myocardium from untreated age-matched NT and SHR, and cariporide-treated (low-and high-dose) SHR rats. An enlarged CSA is observed in the myocytes of the hypertrophied myocardium of untreated SHR in accordance to the overall results shown in Fig. 3 . The increase in CSA was reversed by cariporide both with the low-and the high-dose treatment. Fig. 5 shows length-tension curves of isolated left ventricular papillary muscles from untreated age-matched NT and SHR, and cariporide-treated (low-and high-dose) SHR rats. The muscles isolated from hypertensive hy- ventricle (LVCVF) of age-matched untreated NT, unthe extent of myocardial fibrosis in SHR [20] , serum PIP treated SHR, and the low-and high-dose cariporide-treated levels were determined in the normotensive, hypertensive SHR is shown in Fig. 5 , inset. The increase in LVCVF in and hypertensive rats treated with cariporide and these data the myocardium of the SHR is in agreement with previous are shown in Fig. 6 . The increased levels of PIP in the reports [19, 20] . The treatment with the NHE-1 inhibitor blood of SHR compared to NT rats are in agreement with did not result in a significant change of the LVCVF.
the previously reported value [20] . Neither low-dose nor Since the increase in serum levels of carboxyterminal high-dose cariporide treatment resulted in a significant propeptide of procollagen type I (PIP), a marker of change of PIP levels in SHR. These data are in agreement collagen type I synthesis, has been shown to correlate with with the lack of regression of the increased stiffness and LVCVF. Again, the possibility that it would be necessary to have a longer duration of the treatment to obtain a decrease in PIP should be considered, taking into account that 20 weeks of treatment are required to decrease the PIP levels with an ACE inhibitor [20] .
Discussion
This is the first report to document regression of myocardial hypertrophy by an orally administered specific NHE-1 inhibitor. This effect was achieved with a slight decrease of |6 mmHg from pretreatment SBP value -4] . A role for endogenous ET-1 locally and the second one shows the prevention of cardiomyocyte produced and secreted by cardiomyocytes in the mechahypertrophy after myocardial infarction [22] at a dosage nism of Ang II-induced cardiac hypertrophy was proposed similar to the lower one used in our study. [28] . Both the dosage and the duration of the cariporide Stretch-induced release of Ang II and its autocrine link treatment used in the present experiments deserve some with myocyte hypertrophy was demonstrated by consideration. A wide range of cariporide dosages have Sadoshima et al. [5] in isolated neonatal rat cardiac cells. been used by different investigators, and ours were either
In the same preparation, the group of Yamazaki showed lower than [21, 23] or similar to [22, 24] those of some that whereas NHE inhibition partially attenuated the previous reports. Although we did not measure circulating increase in protein synthesis and MAP kinases activation cariporide levels, the effect to regress and prevent further promoted by stretch [7, 29] , it did not inhibit Ang II-and increase in cardiac hypertrophy was evident. In addition,
ET-1-induced activation of these kinases [7] . The inrsk the fact that similar effects were obtained with the two volvement of MAP kinase and p90 -dependent phosdoses of cariporide used shows that this chronic treatment phorylation of the NHE in ET-1-induced stimulation of the was close to, if not at, the maximal effect for decreasing antiporter was recently demonstrated by Moor and Fliegel cardiomyocyte size. The possibility of tissue accumulation [30] . of the NHE-1 inhibitor should also be considered.
We may speculate that if an enhanced activity of the fractions. However, the increased stiffness detected in the signal for cardiac hypertrophy is supported by numerous papillary muscles of SHR suggests the possibility of studies [31] [32] [33] [34] [35] . Yamazaki et al. [36] suggested two alterations in collagen cross-linking [25] . The duration of independent hypertrophic pathways, one elicited by methe treatment in this study was too short as to ascertain chanical stretch and linked to NHE activation and another whether or not this pharmacological intervention would linked to Ang II or ET-1 without involvement of NHE also decrease fibrosis, or induce a total regression of heart activation. Our experiments in multicellular preparations weight. Results obtained with different antihypertensive from adult myocardium would support the contention that treatments on hypertrophied myocardium suggest that the Ang II, ET-1 and NHE are all steps of a single chain of myocyte and nonmyocyte cells grow independently of each events beginning with the release of Ang II and ending 1 other and that myocyte size declines more rapidly than the with the increase in Na due to NHE activation by ET-1.
i 1 involution of collagen [26] . Actually, whereas regression The notion that an increase in intracellular Na leads to i 21 of myocyte size was obtained after 6 weeks of antia secondary increase in Ca is supported by several i 1 hypertensive treatment, no regression of collagen was studies [2, 37, 38] . Furthermore, the link between Na observed at that time [27] . Since previous studies have influx, activation of PKC-d and´, and hypertrophy has shown that regression of collagen and normalization of PIP been previously suggested [39] . Although stretch-sensitive levels can be achieved with extended treatment with other channels are apparently good candidates to be analyzed as pharmacological interventions [19, 20] , it appears that regards their possible role in the mechano-transduction longer treatments would be necessary to establish whether mechanism, they do not seem to play any role in this a similar result could happen with cariporide. In this pathway [5, 7] . regard, ongoing experiments blocking NHE-1 for longer In summary, we report a regression of the carperiods will allow us to learn whether or not this novel diomyocyte hypertrophy in SHR after 1-month of NHE-1 pharmacological intervention is able to decrease myocarblockade. This regression of myocyte size occurred withdial fibrosis and stiffness. out significant changes in the augmented serum PIP levels, In order to discuss the possible mechanisms by which LVCVF and myocardial stiffness. These novel findings the chronic blockade of the NHE-1 may induce the may help to find the way to develop new therapeutic regression of cardiac hypertrophy it is necessary to review strategies for the treatment of cardiac hypertrophy. the available data linking the enhanced activity of the NHE-1 to hypertrophic mechanisms. In the first place, an enhanced activity of the NHE-1 in the hypertrophied myocardium of the SHR has been reported [8, 9] . Also, the Acknowledgements regression of the cardiac hypertrophy induced by ACEí nhibition was accompanied by normalization of NHE This study was supported in part by grant Ramoñá ctivity [10] . We also reported that NHE activation is an Carrillo-Arturo Onativia, Ministerio de Salud de la Nacion, early signal elicited by the stretch of papillary muscles [1] Argentina, to H.E. Cingolani. The technical assistance of that results from an autocrine / paracrine release of Ang II Laura Paoli and Rosa Villegas is acknowledged.
